Nucana PLC cash flow statement NCNA
Annual
Quarterly
No matching figures were found for this statement.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NCNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Edinburgh, United Kingdom
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1709626
- Former names
- NuCana BioMed Ltd (until Aug 4, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.